知镜 Cognispect · 医学文献与研究工作台

Whole-Genome HPV Liquid Biopsy for HPV-Associated Cancer Detection and Viral Physical State Classification.

Fisch AS, Abruzzo AR, Eldfors S, Das D, Wang Q, Lumaj G, Shukla S, Gockley AA, Wo JY, Hong TS, Russo AL, Richmon JD, Alzumaili BA, Faquin WC, Sadow PM, Faden DL.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2026-11-01 · PMID 42606335

文献摘要

Purpose Human papillomavirus (HPV)-associated carcinomas (HPV+ cancers) account for 5% of all cancers. Circulating tumor HPV DNA (ctHPVDNA) assays for HPV+ cancer surveillance have limited prognostic utility at the time of cancer diagnosis. Although HPV integration into the host genome is a proven tissue-based biomarker predicting poor clinical outcomes, existing clinically utilized ctHPVDNA assays cannot classify the viral physical state. Experimental design We previously developed HPV-DeepSeek, a multifeature HPV whole-genome sequencing liquid biopsy with 99% diagnostic accuracy at the time of HPV+ oropharyngeal cancer diagnosis. We tested the diagnostic accuracy of HPV-DeepSeek in a cohort of 235 HPV+ cancers across 9 anatomic sites and used a novel blood-based computational classifier to infer the HPV genome physical state from plasma, termed HPV sequencing-based integration analysis (HPV-SIGNAL), to assess its prognostic potential. Results HPV-DeepSeek achieved 99% sensitivity and specificity. In 189 eligible samples, HPV-SIGNAL identified 4 viral physical states: episomal-only (n = 71), episomal-rearranged (n = 52), integrated-mixed (n = 57), and integrated-clonal (n = 9), which were confirmed and further elucidated via 3 orthogonal tissue and blood approaches. Patients harboring integrated viral states in blood exhibited significantly worse age-adjusted and American Joint Committee on Cancer stage-adjusted progression-free survival [PFS; HR, 2.78; 95% confidence interval (CI), 1.30-5.99; P = 0.009] and overall survival (OS; HR, 2.95; 95% CI, 1.01-8.61; P = 0.048) compared with patients with episomal states. Conclusions HPV whole-genome sequencing liquid biopsy has high diagnostic accuracy across HPV+ cancer types and can be used to identify and classify HPV physical states from blood. Patients with integrated viral states detected in blood demonstrated worse PFS and OS, suggesting that blood-based HPV physical state classification could be used as a prognostic tool at the time of cancer diagnosis.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。